GL Pharma is recalling a specific batch of Oxylan 40mg prolonged-release tablets due to out of specification results for dissolution during routine stability testing.
MDR 158-08/20Company Name
GL Pharma GmbHProduct description
Oxylan 40mg prolonged-release tablets, PL 21597/0064
Batch NumberExpiry DatePack SizeFirst Distributed
Active pharmaceutical ingredient: oxycodone hydrochloride
Stop supplying the above batch immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.Further information
For medical information enquiries please contact [email protected]
For stock control enquiries please contact [email protected]
Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.
NHS England and NHS Improvement Regional Offices are asked to forward this alert to community pharmacy contractors.
Country of origin
Country for notification
Source of the alert
MHRA - Medicines & Healthcare products Regulatory Agency, www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Download the application
Download our application and monitor threats! Scan products and feel safe every day. Check it out today!